MediWound Ltd.
Company Information
Industry
Medicinal Chemicals & Botanical Products
SIC Code
2833
Entity Type
other
SEC Category
Accelerated filer
State of Incorporation
Israel
Business Address
42 HAYARKON STREET, YAVNE, L3, 8122745
Mailing Address
42 HAYARKON STREET, YAVNE, L3, 8122745
Phone
972779714100
Fiscal Year End
1231
EIN
000000000
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 6-K Foreign company current report | April 2, 2026 | View on SEC |
| 6-K Foreign company current report | March 30, 2026 | View on SEC |
| 3 Initial insider ownership report | March 25, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
Annual Reports
20-F
March 5, 2026
- NexoBrid's reinforced role in national emergency preparedness through BARDA engagement.
- Strategic partnerships with Vericel for North American commercialization and Teva Pharmaceuticals.
Related Companies
Companies in the same industry (SIC: 2833)
HEALTHY EXTRACTS INC.
HYEX
Medicinal Chemicals & Botanical Products
MANNATECH INC
MTEX
Medicinal Chemicals & Botanical Products
Synergy CHC Corp.
SNYR
Medicinal Chemicals & Botanical Products
Tilray Brands, Inc.
TLRY
Medicinal Chemicals & Botanical Products
Charlie's Holdings, Inc.
CHUC
Medicinal Chemicals & Botanical Products
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.